Literature DB >> 17459680

Hypofractionation in clinical trials for prostate cancer.

P J Hoskin, D P Dearnaley.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17459680     DOI： 10.1016/j.clon.2007.03.007

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  2 in total

1.  Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET).

Authors:  K Harrington; E Hall; M Hawkins; A Henry; R MacKay; T Maughan; A McDonald; C Nutting; U Oelfke; D Sebag-Montefiore; R A Sharma; M van Herk; C Faivre-Finn
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-08-12       Impact factor: 4.126

2.  Hypofractionated helical tomotherapy using 2.5-2.6 Gy daily fractions for localized prostate cancer.

Authors:  Jose Luis Lopez Guerra; Nicolas Isa; Raul Matute; Moises Russo; Fernando Puebla; Michelle Miran Kim; Alberto Sanchez-Reyes; Cesar Beltran; Javier Jaen; Celine Bourgier; Hugo Marsiglia
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.